stockrow
Saturday 7 November 2026
Export VNRX’s income statement to Excel — free account
VolitionRX Limited
VNRX Healthcare Medical Devices
VolitionRX Limited’s revenue for fiscal 2025 (year ended December 2025) was $1.7 million, up 40.0% from fiscal 2024.
- Revenue
- −1.97%
- EPS
- +29.2%
- Free cash flow
- +18.6%
- Total debt
- +7.56%
Quarter to June 2026, against a year earlier
0.20
0.01
+5.26%
Follow VNRX
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 3 | 2 | 4 | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
P/S ratio |
15.80 | 42.09 | 96.47 | 431.74 | 1,837.11 | 13,144.72 | 2,649.26 | — | — | — |
Altman Z-Score |
(62.83) | (43.15) | (12.98) | (15.09) | 0.46 | 2.79 | 8.09 | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Altman Z″-Score (non-manufacturers) |
(151.18) | (102.31) | (29.50) | (43.50) | (17.58) | (13.92) | (12.49) | — | — | — |
Beneish M-Score |
(4.07) | (2.29) | (3.69) | (3.90) | 0.95 | — | — | — | — | — |
P/Operating CF |
(4.97) | (9.56) | 11.60 | (22.79) | (37.50) | (64.42) | (71.48) | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 9.33 | 10.81 | 13.08 | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 9.45 | 11.03 | 13.43 | — | — | — |
EV/Sales |
21.46 | 43.61 | 76.48 | 410.25 | 1,648.20 | 11,995.87 | 2,456.46 | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
EV/Operating CF |
(1.88) | (2.08) | (3.28) | (8.23) | (7.11) | (9.76) | (13.52) | — | — | — |
EV/FCF |
(1.85) | (2.03) | (3.09) | (7.44) | (6.78) | (8.85) | (12.94) | — | — | — |
Quick Ratio |
0.12 | 0.43 | 2.35 | 0.63 | 3.16 | 3.12 | 4.40 | 5.75 | 4.42 | 10.66 |
Current Ratio |
0.17 | 0.52 | 2.44 | 0.70 | 3.37 | 3.26 | 4.55 | 5.96 | 4.61 | 10.82 |
Net Debt/EBITDA |
(0.52) | (0.07) | 0.44 | 0.21 | 0.62 | 0.75 | 0.88 | 0.60 | 0.53 | 1.68 |
Debt/Assets |
157.70% | 54.70% | 18.72% | 23.41% | 13.02% | 15.49% | 16.21% | 17.84% | 17.99% | 5.47% |
Debt/Equity |
(0.31) | (0.20) | (0.60) | (1.37) | 0.20 | 0.25 | 0.24 | 0.26 | 0.26 | 0.06 |
Asset Turnover |
0.21 | 0.07 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.84 | 0.96 | 0.51 | 0.50 | 0.78 | 0.81 | 0.79 | 0.82 | 0.83 | 0.74 |
Capex/Depreciation |
(0.03) | (0.52) | (0.94) | (1.68) | (1.03) | (2.30) | (0.76) | (0.47) | (2.70) | (1.34) |
Interest Coverage |
(40.85) | (79.39) | (162.40) | (183.59) | (181.86) | (163.70) | (126.72) | (161.39) | (201.04) | (609.32) |
| 75.71% | 154.90% | 596.65% | (414.78%) | (157.66%) | (133.49%) | (122.24%) | (162.99%) | (94.88%) | (87.48%) | |
| (286.58%) | (144.41%) | (152.75%) | (132.22%) | (99.98%) | (85.80%) | (83.03%) | (112.16%) | (75.05%) | (73.39%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (2,457.42%) | (1,476.85%) | (1,468.05%) | (609.86%) | (371.41%) | (915.17%) |
Return on Tangible Assets |
380.28% | (3,878.58%) | (191.60%) | (16,909.94%) | (131.61%) | (105.64%) | (96.53%) | (122.60%) | (125.62%) | (53.88%) |
Average Days of Receivables |
67.15 | 32.73 | 114.21 | 86.49 | 50.69 | 193.40 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
583.61% | 1,167.94% | 2,521.80% | 5,004.24% | 14,469.33% | 108,461.94% | 60,604.09% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
774.85% | 1,122.98% | 2,219.98% | 5,467.85% | 17,111.89% | 50,204.48% | 33,314.62% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.05 | 0.03 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.02 |
Share Based Compensation of Revenue |
100.71% | 102.84% | 295.31% | 1,016.55% | 2,967.00% | 10,384.33% | 8,579.53% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(1.48) | (0.61) | (0.20) | (0.07) | 0.07 | 0.06 | 0.06 | — | — | — |
Graham Number |
25.68 | 29.01 | 23.69 | 16.72 | 0.00 | 0.00 | 0.00 | — | — | — |
Earnings Yield |
(86.11%) | (51.67%) | (48.57%) | (23.01%) | (15.92%) | (11.83%) | (8.86%) | — | — | — |
Free Cash Flow Yield |
(73.53%) | (50.98%) | (25.67%) | (12.78%) | (13.23%) | (10.31%) | (7.16%) | — | — | — |
Revenue per Share |
0.32 | 0.29 | 0.22 | 0.11 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(3.68) | (5.98) | (5.07) | (5.52) | (7.92) | (7.27) | (6.50) | (9.39) | (9.24) | (7.69) |
Capex per Share |
(0.02) | (0.13) | (0.30) | (0.57) | (0.37) | (0.73) | (0.26) | (0.19) | (1.08) | (0.36) |
Free Cash Flow per Share |
(3.70) | (6.12) | (5.38) | (6.09) | (8.29) | (8.00) | (6.76) | (9.58) | (10.32) | (8.05) |
Cash per Share |
0.21 | 0.75 | 5.82 | 3.93 | 7.82 | 8.59 | 8.66 | 8.56 | 7.67 | 18.81 |
Shareholders Equity per Share |
(6.66) | (6.03) | (2.45) | (1.13) | 6.73 | 7.20 | 7.25 | 7.74 | 7.55 | 18.37 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(6.66) | (6.03) | (2.45) | (1.13) | 6.73 | 7.20 | 7.25 | 7.74 | 7.55 | 18.37 |
Free Cash Flow |
(19.77) | (26.47) | (19.15) | (16.85) | (21.83) | (18.11) | (13.25) | (15.03) | (13.62) | (9.28) |
Working Capital |
(10.17) | (3.73) | 12.91 | (5.21) | 15.46 | 14.10 | 13.70 | 11.57 | 8.28 | 19.98 |
Capital Expenditures |
(0.09) | (0.57) | (1.08) | (1.57) | (0.97) | (1.65) | (0.51) | (0.30) | (1.43) | (0.42) |
Net Current Asset Value |
(40.43) | (31.45) | (14.81) | (9.25) | 12.21 | 10.47 | 10.46 | 8.55 | 5.90 | 18.45 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Capex to Sales |
0.05 | 0.47 | 1.40 | 5.12 | 10.82 | 122.96 | 29.90 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.73 | 0.25 | 0.21 | 0.17 | 0.19 | 0.14 | 0.23 | 0.20 | 0.15 | 0.15 |
Cash ROIC |
83.81% | 149.52% | (111.00%) | (140.14%) | (52.12%) | (45.52%) | (38.28%) | (52.41%) | (59.98%) | (20.99%) |
Accounts Receivable Turnover |
8.06 | 6.98 | 4.92 | 7.20 | 9.18 | 0.23 | 0.00 | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | — | — | — | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.21 | 0.18 | 0.16 | 0.04 | 0.01 | 0.06 | — | — | — | — |
Average Payables |
2.84 | 2.99 | 3.13 | 2.29 | 1.54 | 1.08 | 0.72 | 0.58 | 0.32 | 0.30 |
Average Assets |
8.15 | 18.68 | 23.12 | 22.89 | 26.82 | 23.72 | 19.39 | 16.06 | 19.68 | 16.22 |
Average Common Equity |
(30.85) | (17.41) | (5.92) | 7.30 | 17.01 | 15.25 | 13.17 | 11.05 | 15.57 | 13.61 |
Columns are period end dates · fundamentals updated 26 Oct 2026